Un programa basado en la web para ayudar a los cuidadores de pacientes pulmonares a conocer los recursos de atención de apoyo disponibles (CONNECT)
Planificación oncológica comunitaria en múltiples sitios para la intervención CONNECT dirigida a cuidadores de cáncer de pulmón
Clinical trial that tests the feasibility of a web based caregiver support resource, along with caregiver navigation sessions for caregivers of patients with stage II-IV lung cancer. The Caregiver Oncology Needs Evaluation Tool (CONNECT) is a novel web-based intervention designed for the community oncology setting, to systematically connect lung cancer caregivers with tailored supportive care resources. Lung cancer caregivers provide critical and challenging care for their loved ones and are at risk for their own negative psychosocial and physical outcomes. Implementing the CONNECT program along with caregiver navigation may provide additional support to caregivers of patients with stage II-IV lung cancer.
Descripción general del estudio
Estado
Condiciones
Descripción detallada
This study is a multi-site randomized pilot trial enrolling 120 lung cancer caregiver-patient dyads (i.e., lung cancer caregivers (n=120) and their care-recipients (n=120)) across approximately 8-12 practices to assess the multi-site feasibility of a caregiver technology-based intervention (CONNECT) to identify caregivers' needs and connect them with supportive care resources. Caregivers will be randomized 1:1:1 to either the CONNECT intervention, usual care comparison group or generic resource list comparison group. CONNECT is a web-based intervention that empowers and educates caregivers about the benefits of supportive care services and systematically identifies unmet needs to connect lung cancer caregivers with tailored supportive care resources. The Central Caregiver Navigator will assist caregivers with resolving barriers to accessing resources and work with the Local Practice Referral Coordinator to process referrals. Caregivers and patients will complete measures at baseline (prior to caregiver randomization), and 12 and 24 weeks after baseline. Feasibility measures (retention, accrual rates, and participation) will be evaluated to inform the future trial. The Local Practice Referral Coordinator for each practice will report on time needed for practice participation, referral processes, and communication processes with the Central Caregiver Navigator.
Participants (i.e., patients or care-recipients) will be asked to complete study surveys at three time points:
- After consenting and before randomization of participant and caregiver. (Initial survey)
- Approximately 12 weeks after completing the first survey (12-week survey)
- Approximately 24 weeks after completing the first survey (24-week survey)
Each survey will take about 30-45 minutes to complete. The forms will ask about things such as demographics (sex, race, etc.), cancer symptoms, satisfaction with cancer care and health behaviors. You don't have to answer any question that makes you feel uncomfortable. These surveys can be done remotely over the internet, in the clinic, by phone or by mail.
Caregivers will also complete surveys at three time points and will be assigned to 1 of 3 study groups:
- Group 1 will be given the usual care provided at your clinic. At the completion of the study, this group will be given the generic supportive care resource list for their use that Group 2 received.
- Group 2 will be provided with a generic supportive care resource list.
- Group 3 will be asked to watch a brief video and complete the web-based CONNECT program either in the clinic or on your own device. The CONNECT program is designed to help identify any unmet needs and connect the caregiver with tailored supportive care resources, based on specific needs. The CONNECT Navigator will follow-up with within 2 business days of completion of the program and again 4 weeks later.
Caregiver Participants (Group 1, 2 and 3) will be asked to complete study surveys at three time points:
- After consenting and before randomization of participant and caregiver. (Initial survey)
- Approximately 12 weeks after completing the first survey (12-week survey)
- Approximately 24 weeks after completing the first survey (24-week survey)
Each survey will take about 35-45 minutes to complete. The forms will ask about things such as demographics (sex, race, etc.), caregiving experience, use of supportive care resources, quality of life, mood, and social needs (housing, transportation, utilities, etc). You don't have to answer any question that makes you feel uncomfortable.
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Colorado
-
Denver, Colorado, Estados Unidos, 80205
- Kaiser Permanente-Franklin
-
Lafayette, Colorado, Estados Unidos, 80026
- Kaiser Permanente - Rock Creek
-
Lone Tree, Colorado, Estados Unidos, 80124
- Kaiser Permanente - Lone Tree
-
-
Delaware
-
Millville, Delaware, Estados Unidos, 19967
- Beebe South Coastal Health Campus
-
Rehoboth Beach, Delaware, Estados Unidos, 19971
- Beebe Health Campus
-
-
Georgia
-
Augusta, Georgia, Estados Unidos, 30912
- Augusta University Medical Center
-
-
Hawaii
-
Honolulu, Hawaii, Estados Unidos, 96813
- Hawaii Cancer Care Inc - Waterfront Plaza
-
‘Aiea, Hawaii, Estados Unidos, 96701
- Hawaii Cancer Care - Westridge
-
-
Missouri
-
Osage Beach, Missouri, Estados Unidos, 65065
- Lake Regional Hospital
-
Springfield, Missouri, Estados Unidos, 65807
- CoxHealth South Hospital
-
-
New York
-
The Bronx, New York, Estados Unidos, 10461
- Montefiore Medical Center-Einstein Campus
-
-
North Carolina
-
Winston-Salem, North Carolina, Estados Unidos, 27157
- Wake Forest NCORP Research Base
-
-
Pennsylvania
-
Scranton, Pennsylvania, Estados Unidos, 18510
- Community Medical Center
-
Wilkes-Barre, Pennsylvania, Estados Unidos, 18711
- Geisinger Wyoming Valley/Henry Cancer Center
-
-
South Carolina
-
Gaffney, South Carolina, Estados Unidos, 29341
- Gibbs Cancer Center-Gaffney
-
Greenville, South Carolina, Estados Unidos, 29615
- Prisma Health Cancer Institute - Eastside
-
Greenville, South Carolina, Estados Unidos, 29605
- Prisma Health Cancer Institute - Butternut
-
Greer, South Carolina, Estados Unidos, 29651
- Gibbs Cancer Center-Pelham
-
Spartanburg, South Carolina, Estados Unidos, 29303
- Spartanburg Medical Center
-
Union, South Carolina, Estados Unidos, 29379
- MGC Hematology Oncology-Union
-
-
Wisconsin
-
Appleton, Wisconsin, Estados Unidos, 54911
- ThedaCare Regional Cancer Center
-
Green Bay, Wisconsin, Estados Unidos, 54311
- Aurora BayCare Medical Center
-
Kenosha, Wisconsin, Estados Unidos, 53142
- Aurora Cancer Care-Kenosha South
-
Milwaukee, Wisconsin, Estados Unidos, 53215
- Aurora Saint Luke's Medical Center
-
Neenah, Wisconsin, Estados Unidos, 54956
- ThedaCare Regional Medical Center - Neenah
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Patient Inclusion Criteria:
- Must be ≥ 18 years of age, as this study is focused on the experience of adult patient-caregiver dyads
- Must have a current diagnosis of new (i.e., initial diagnosis) or recurrent stage II-IV lung cancer
- Must be enrolled after the start of anticancer systemic therapy (+/- radiation therapy) with at least 9 weeks of any planned anticancer treatment remaining
- Must be ambulatory and up (i.e., not bedridden) more than 50% of waking hours
- Must self-report receiving informal (i.e., not professional) care from a caregiver who meets the study caregiver criteria and who is willing to participate
Caregiver Inclusion Criteria:
- Must be ≥18 years of age, as this study is focused on the experience of adult patient-caregiver dyads
- Must self-report providing informal (i.e. not professional) care during cancer treatment for a patient who meets the patient criteria and who is willing to participate
- Must have access to the internet at home or be willing to use CONNECT in the clinic
- Must have access to telephone to complete sessions with the central caregiver navigator
Patient Exclusion Criteria:
- Patients who have completed treatment for their lung cancer at the time of study enrollment
- Enrolled in hospice care
- Unable to read and English and not willing to have someone read surveys for them
Caregiver Exclusion Criteria:
- Self-report currently receiving cancer treatment
- Unable to read and communicate in English, as the CONNECT intervention is currently only available in English
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Cuidados de apoyo
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Comparador activo: Group 1 (Standard care followed by generic resource list)
Caregivers receive standard care and are then given a generic resource list at week 24. |
Receive a generic resource list |
|
Comparador activo: Group 2 (Generic resource list)
Caregiver receive a generic resource list at the start of the study. |
Receive a generic resource list |
|
Experimental: Group 3 (CONNECT, personalized list, and navigation)
Caregivers receive access to the CONNECT tool, watch an educational video on self care and receive a personalized list of resources based on caregiver preferences. Caregivers also receive access to and complete at least 2 calls, at baseline and at week 4, with a caregiver navigator to review the resource list and address any additional needs. |
Receive personalized resource list Receive access to CONNECT tool Complete calls with caregiver navigator
Otros nombres:
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Caregiver retention at 12 weeks
Periodo de tiempo: At 12 weeks
|
Calculated as the following: Number of caregivers who complete at least 75% of the 12-week assessments divided by the number randomized. Retention will be estimated and reported along with an exact 95% confidence interval. |
At 12 weeks
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Caregiver accrual rate
Periodo de tiempo: Upon completion of recruitment, approximately 12 months
|
Number of caregivers who agree to participate divided by the number of months of recruitment |
Upon completion of recruitment, approximately 12 months
|
|
Caregiver participation
Periodo de tiempo: Upon completion of recruitment, approximately 12 months
|
Proportion of eligible caregivers who agreed to participate |
Upon completion of recruitment, approximately 12 months
|
|
Caregiver retention at 24 weeks
Periodo de tiempo: At 24 weeks
|
Number of caregivers who complete at least 75% of the 24-week assessments divided by the number randomized. |
At 24 weeks
|
|
Caregiver acceptability
Periodo de tiempo: At 12 weeks
|
Self-report survey developed for this study to assess the degree to which caregivers found different aspects of CONNECT, the generic resource list, or usual care helpful using a Likert response from 0 (Not at all) to 5 (Very Much) |
At 12 weeks
|
|
Average time (minutes) needed for training for Local Practice Referral Coordinator
Periodo de tiempo: At completion of training, up to 6 months
|
Will be summarized across practices using mean, median, standard deviation and interquartile range. |
At completion of training, up to 6 months
|
|
Desired modality for training (e.g., live webinar, recorded video, paper materials) for Local Practice Referral Coordinator
Periodo de tiempo: At completion of training, up to 6 months
|
Will be summarized using appropriate descriptive statistics. |
At completion of training, up to 6 months
|
|
Average time (minutes) needed to identify and enter local resources into the Caregiver Oncology Needs Evaluation Tool (CONNECT) database
Periodo de tiempo: At conclusion of practice intervention activities, an average of 18 months
|
Will be summarized across practices using mean, median, standard deviation and interquartile range. |
At conclusion of practice intervention activities, an average of 18 months
|
|
Frequency of needed resource updates in the CONNECT database
Periodo de tiempo: Up to completion of practice intervention activities, an average of 18 months
|
Will be summarized across practices using mean, median, standard deviation and interquartile range |
Up to completion of practice intervention activities, an average of 18 months
|
|
Average time (minutes) spent by the Central Caregiver Navigator and Local Practice Referral Coordinators with each caregiver in the CONNECT arm
Periodo de tiempo: Up to completion of practice intervention activities, an average of 18 months
|
Will be summarized across practices using mean, median, standard deviation and interquartile range. |
Up to completion of practice intervention activities, an average of 18 months
|
|
Modality of contact (e.g. phone, virtual web meeting, email) made by the Central Caregiver Navigator and Local Practice Referral Coordinators with each caregiver in the CONNECT arm
Periodo de tiempo: Up to completion of practice intervention activities, an average of 18 months
|
Will be summarized using appropriate descriptive statistics. |
Up to completion of practice intervention activities, an average of 18 months
|
|
Number of contacts made by the Central Caregiver Navigator and Local Practice Referral Coordinators with each caregiver in the CONNECT arm
Periodo de tiempo: Up to completion of practice intervention activities, an average of 18 months
|
Will be summarized across practices using mean, median, standard deviation and interquartile range. |
Up to completion of practice intervention activities, an average of 18 months
|
|
Number of referrals facilitated by the Local Practice Referral Coordinator and Central Caregiver Navigator
Periodo de tiempo: Up to completion of practice intervention activities, an average of 18 months
|
Will be summarized across practices using mean, median, standard deviation and interquartile range. |
Up to completion of practice intervention activities, an average of 18 months
|
|
Type of referrals (e.g., in person, online) facilitated by the Local Practice Referral Coordinator and Central Caregiver Navigator
Periodo de tiempo: Up to completion of practice intervention activities, an average of 18 months
|
Will be summarized using appropriate descriptive statistics. |
Up to completion of practice intervention activities, an average of 18 months
|
|
Average time (minutes) needed to communicate for Central Caregiver Navigator and Local Practice Referral Coordinator
Periodo de tiempo: Up to completion of practice intervention activities, an average of 18 months
|
Will be summarized across practices using mean, median, standard deviation and interquartile range. |
Up to completion of practice intervention activities, an average of 18 months
|
|
Modalities used for communication (e.g., phone, virtual web meeting, email) for Central Caregiver Navigator and Local Practice Referral Coordinator
Periodo de tiempo: Up to completion of practice intervention activities, an average of 18 months
|
Will be summarized using appropriate descriptive statistics. |
Up to completion of practice intervention activities, an average of 18 months
|
|
Improvements for the future trial from Local Practice Referral Coordinator's perspectives from a survey at the end of the study
Periodo de tiempo: At completion of practice intervention activities, an average of 18 months
|
Will be summarized using appropriate descriptive statistics. |
At completion of practice intervention activities, an average of 18 months
|
Otras medidas de resultado
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Patient accrual rate
Periodo de tiempo: Upon completion of recruitment, approximately 12 months
|
Number of patients who agree to participate divided by the number of months of recruitment |
Upon completion of recruitment, approximately 12 months
|
|
Patient participation rate
Periodo de tiempo: Upon completion of recruitment, approximately 12 months
|
Proportion of eligible patients who agreed to participate |
Upon completion of recruitment, approximately 12 months
|
|
Patient retention at 12 weeks
Periodo de tiempo: At 12 weeks
|
Number of patients who complete at least 75% of the 12-week assessments divided by the number randomized |
At 12 weeks
|
|
Patient retention at 24 weeks
Periodo de tiempo: At 24 weeks
|
Number of patients who complete at least 75% of the 24-week assessments divided by the number randomized |
At 24 weeks
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Silla de estudio: Kathryn Weaver, PhD, Wake Forest University Health Sciences
Publicaciones y enlaces útiles
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
- Neoplasias por sitio
- Neoplasias
- Enfermedades de las vías respiratorias
- Enfermedades pulmonares
- Neoplasias de las vías respiratorias
- Neoplasias torácicas
- Neoplasias Pulmonares
- Administración de Servicios de Salud
- Terapéutica
- Atención al paciente
- Servicios de salud
- Instalaciones de atención médica Fuerza laboral y servicios
- Gestión de atención al paciente
- Atención médica integral
- Atención centrada en el paciente
- Atención primaria de salud
- Cuidados paliativos
- Navegación del paciente
Otros números de identificación del estudio
- IRB00112187
- NCI-2023-10870 (Otro identificador: NCI Trial Identifier)
- Lead Organization Identifier (Otro identificador: WF-2301CD)
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
Wake Forest NCORP Research Base is committed to following the NIH Statement on Sharing Research Data (http://grants.nih.gov/grants/guide/notice-files/NOT-OD-03-032.html). As of July 2018, the WF NCORP RB signed an agreement with NCI to contribute de-identified data and data dictionaries from clinical trials conducted through our RB to the NCI NCTN/NCORP data archive within 6 months of primary and non-primary publications of phase II/III and phase III trials to https://nctn-data-archive.nci.nih.gov/. This will become the primary means for sharing raw data, and we will adhere to the guidelines spelled out in the NCTN/NCORP Data Archive Usage Guide. De-identified data from studies not covered by the agreement (e.g., phase II and observational studies) will be made available upon request. All data files will be de-identified. De-identification procedures will meet the HIPAA criteria as detailed in the Code of Federal Regulations, Part 45, Section 164.514.
Marco de tiempo para compartir IPD
6 months after publication for a 2 year duration
Criterios de acceso compartido de IPD
upon request to NCORP@wakehealth.edu
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .